“The foundation’s latest gift will allow us to continue to explore important scientific breakthroughs that are high-risk, high-reward endeavors, rarely funded through government grants,” Southern Research president says
While HPLC and mass spec make inroads into nontraditional markets, interest remains in molecular techniques that address the unique needs of clinicians and drug developers.
The technology is an influenza B vaccine virus “backbone” that would allow producers to grow vaccine viruses at high yield in mammalian cell culture rather than in eggs